Impact of the COVID-19 pandemic on research and teaching in nanosciences and nanotechnology in Mexico
Article Sidebar
Main Article Content
Abstract
Since Mexico began to take measures against the COVID-19 pandemic in March 2020, the social, economic and political impacts and their implications for research, development and teaching in multiple areas of knowledge have diversified and deepened. Nanosciences and nanotechnology (N&N) are certainly no exception. This paper presents the main results of a broad survey carried out among researchers in the country working in some area of N&N, which represents a third of said community. It analyzes the conditions of work and daily life in confinement, the productivity and development of research projects, institutional support, access to funds and financing management, and the impacts on the qualification of highly qualified personnel and on teaching. It is concluded that, in general terms, the delay in the research and qualification of highly qualified personnel in N&N is located, at least, in the range of 2 to 3 years, a delay that can be a good opportunity to promote better practices of research, teaching, institutional administration and management that allow building a desirable resilience in the scientific-educational activity of the country, both in the N&N field and in other areas.
Downloads
Article Details
Mundo Nano. Revista Interdisciplinaria en Nanociencias y Nanotecnología por Universidad Nacional Autónoma de México se distribuye bajo una Licencia Creative Commons Atribución-NoComercial 4.0 Internacional.
Basada en una obra en http://www.mundonano.unam.mx.
References
Adu-Amankwaah, Joseph; Mprah, Richard; Adekunlle, Oluwafemi; Ndzie Noah, Marie et al. 2020. The cardiovascular aspect of COVID-19. Annals of Medicine, 53(1): 227-236. https://doi.org/10.1080/07853890.2020.1861644
Bloom, Jesse; Chan, Yujia A; Baric, Ralph S; Bjorkman, Pamela; Cobey, Sarah et al. 2021. Investigate the origins of COVID-19. Science, 372(6543): 694. https://doi.org/10.1126/science.abj0016
Chávez-Sandoval, Blanca E.; Flores-Mendoza, Nallely; Chávez-Recio, Auraamellaly; Balderas-López, José A. y García-Franco, Francisco. 2020. Biosíntesis de nanopartículas de oro (AuNPs) y los agentes reductores implicados en el proceso. Mundo Nano. Revista Interdisciplinaria en Nanociencias y Nanotecnología, 14(27): 1e-12e. https://doi.org/10.22201/ceiich.24485691e.2021.27.69658
Chilazi, Michael; Duffy, Eamon; Thakkar, Aarti y Michos, Erin. 2021. Intermediate and long-term impact of COVID-19 on cardiovascular disease. American College of Cardiology, abril 21. https://www.acc.org/latest-in-cardiology/articles/2021/04/21/13/08/intermediate-and-long-term-impact-of-covid-19-on-cardiovascular-disease
Chung, Mina; Zidar, David; Bristow, Michael; Cameron, Scott; Chan, Timothy et al. 2021. COVID-19 and Cardiovascular disease. Circulation Research, 128(8): 1214-1236. https://doi.org/10.1161/CIRCRESAHA.121.317997
CIMAV. 2008. Diagnóstico y prospectiva de la nanotecnología en México. FUNTEC-SE. México. http://www.2006-2012.economia.gob.mx/files/comunidad_negocios/industria_comercio/Estudios/Diagnostico_y_Prospectiva_Nanotecnologia_Mexico.pdf
De la Torre, Rocío G. y Betancourt, Israel. 2020. Nanomateriales integrados para el desarrollo de equipo de prevención primaria ante el Covid-19. Mundo Nano. Revista Interdisciplinaria en Nanociencias y Nanotecnología, 14(27): 1e-18e. https://doi.org/10.22201/ceiich.24485691e.2021.27.69652
Delgado Ramos, Gian Carlo y López García, David. 2020. Las ciudades ante el COVID-19: nuevas direcciones para la investigación urbana y las políticas públicas. PCTU-INGSA. CDMX, México. https://zenodo.org/record/3894075/files/Ciudades%20ante%20el%20COVID-19.pdf?download=1
Durán Álvarez, Juan C.; Martínez Avelar, Carolina y Mejía Almaguer, Daniel. 2020. El papel de la nanociencia y la nanotecnología en el marco de la pandemia de Covid-19. Mundo Nano. Revista Interdisciplinaria en Nanociencias y Nanotecnología, 14(27): 1e-29e. https://doi.org/10.22201/ceiich.24485691e.2021.27.69647
Florindo, Helena; Kleiner, Ron; Vaskovich-Koubi, Daniella; Acúrcio, Rita et al. 2020. Immune-mediated approaches against COVID-19. Nature Nanotechnology, 15: 630-645. https://doi.org/10.1038/s41565-020-0732-3
FMI. 2021. World Economic Outlook: Managing divergent recoveries. Fondo Monetario Internacional. https://www.imf.org/en/Publications/WEO/Issues/2021/03/23/world-economic-outlook-april-2021
Haider, Najmul; Rothman-Ostrow, Peregrine; Osman, Abdinasir Y.; Arruda, Lia B.; Macfarlane-Berry, Laura et al. 2020. COVID-19 – Zoonosis or Emerging Infectious Disease? Frontiers in Public Health, 8: 596944. https://doi.org/10.3389/fpubh.2020.596944
IFC. 2020. The impact of COVID-19 on the water and sanitation sector. International Finance Corporation. https://www.ifc.org/wps/wcm/connect/126b1a18-23d9-46f3-beb7-047c20885bf6/The+Impact+of+COVID_Water%26Sanitation_final_web.pdf?MOD=AJPERES&CVID=ncaG-hA
INEGI. 2021. Producto Interno Bruto de México durante el cuarto trimestre de 2020. Comunicado de Prensa No. 157/21. 25 de febrero. https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2021/pib_pconst/pib_pconst2021_02.pdf
Kollewe, Julia. 2021. From Pfizer to Moderna: who’s making billions from COVID-19 vaccines? The Guardian, 6 de marzo. https://www.theguardian.com/business/2021/mar/06/from-pfizer-to-moderna-whos-making-billions-from-covid-vaccines
Lammers, Twan; Marios Sofias, Alexandros; Van der Meel, Roy; Schiffelers, Raymond et al. 2020. Dexamethasone nanomedicines for COVID-19. Nature Nanotechnology, 15: 622-624. https://doi.org/10.1038/s41565-020-0752-z
Lancet. 2021. Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics. The Lancet, 397(10274): 562-564. https://doi.org/10.1016/S0140-6736(21)00242-7
Marc, Malgorzata A.; Domínguez-Álvarez, Enrique y Gamazo, Carlos. 2015. Nucleic acid vaccination strategies against infectious diseases. Expert Opinion on Drug Delivery, 12: 1851-1865. https://doi.org/10.1517/17425247.2015.1077559
MHRA. 2020. Public Assessment Report. Authorisation for Temporary Supply. Medicines & Healthcare products Regulatory Agency. Reino Unido. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/944544/COVID19_mRNA_Vaccine_BNT162b2_UKPAR_PFIZER_BIONTECH_15Dec2020.pdf
Milane, Lara y Amiji, Mansoor. 2021. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine. Drug Delivery and Translational Research, https://doi.org/10.1007/s13346-021-00911-y
Navarrete, Alejandro y Treviño, Ricardo. 2020. El ventilador vs COVID-19 que unió a empresas, gobierno y universidad. Tecnológico de Monterrey. 6 de agosto. https://tec.mx/es/noticias/nacional/salud/el-ventilador-vs-covid-19-que-unio-empresas-gobierno-y-universidad
NBSC. 2021. National economy recovered steadily in 2020 with main goals accomplished better than expectation. National Bureau of Statistics of China. 18 de enero. http://www.stats.gov.cn/english/PressRelease/202101/t20210118_1812432.html#:~:text=According%20to%20preliminary%20estimates%2C%20the,last%20year%20at%20comparable%20prices.
Neidleman, Jason; Luo, Xiaoyu; McGregor, Matthew; Xie, Guorui; Murray, Victoria et al. 2021. mRNA vaccines-induced SARS-CoV-2 specific T cells recognize B.I.I7 and B.I.35I variants but differ in longevity and homing properties depending on prior infection status. bioRxiv. https://doi.org/10.1101/2021.05.12.443888
OMS. 2021-A. WHO-convened global study of origins of SARS-CoV-2: China Part. 14 de enero. https://www.who.int/publications/i/item/who-convened-global-study-of-origins-of-sars-cov-2-china-part
OMS. 2021-B. WHO urges countries to build a fairer, healthier world post-COVID-19. 6 de abril. https://www.who.int/news/item/06-04-2021-who-urges-countries-to-build-a-fairer-healthier-world-post-covid-19
Pardi, Norbert; Hogan, Michael; Porter, Frederick y Weissman, Drew. 2018. mRNA vaccines – a new era in vaccinology. Nature Reviews Drug Discovery, 17: 261-279. https://doi.org/10.1038/nrd.2017.243
Pramanik, Avijit; Gao, Ye; Patibandla, Shamily; Mitra, Dipanwita; McCandless, Martin et al. 2021. The rapid diagnosis and effective inhibition of coronavirus using spike antibody attached gold nanoparticles. Nanoscale Advances, 3: 1588-1596. https://doi.org/10.1039/D0NA01007C
Rabiee, Navid; Bagherzadeh, Mojtaba; Ghasemi, Amir; Zare, Hossein; Ahmadi, Sepideh et al. 2020. Point-of-Use Rapid Detection of SARS-CoV-2: Nanotechnology-Enabled Solutions for the COVID-19 Pandemic. International Journal of Molecular Sciences, 21(4): 5126. https://doi.org/10.3390/ijms21145126
Rashidzadeh, Hamid; Danafar, Hossein; Rahimi, Hossein; Mozafari, Faezeh; Salehiabar, Marziyeh et al. 2021. Nanotechnology against the novel coronavirus: diagnosis, treatment, therapy and future perspectives. Nanomedicine, 16(6). https://doi.org/10.2217/nnm-2020-0441
Rodríguez García, Arturo. El CONACYT presenta dos ventiladores para pacientes COVID de diseño mexicano. Proceso, 14 de julio. https://www.proceso.com.mx/nacional/2020/7/14/el-conacyt-presenta-dos-ventiladores-para-pacientes-covid-de-diseno-mexicano-246122.html
Seo, Giwan; Lee, Geonhee; Kim, Mi J.; Baek, Seung-Hwa; Choi, Minsuk et al. 2020. Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor. ACS Nano, 14(4): 5135-5142. https://doi.org/10.1021/acsnano.0c02823
Talebian, Sepehr; Wallace, Gordon; Schroeder, Avi; Stellacci, Francesco y Conde Joao. 2020. Nanotechnology-based disinfectants and sensors for SARS-CoV-2. Nature Nanotechnology, 15: 618-621. https://doi.org/10.1038/s41565-020-0751-0
UAM. 2018. Nano-molécula diseñada por egresada de la UAM, útil en el sector salud y en el cuidado personal. Boletines UAM, 209. 27 de marzo. http://www.comunicacionsocial.uam.mx/boletinesuam/209-18.html
UNWTO. 2020. The Impact of COVID19 on Tourism. World Tourism Organization. https://webunwto.s3.eu-west-1.amazonaws.com/s3fs-public/2020-08/UN-Tourism-Policy-Brief-Visuals.pdf
Vadlamani, Bhaskar; Uppal, Timsy; Verma, Subhash y Misra, Mano. 2020. Functionalized TiO2 nanotube-based electrochemical biosensor for rapid detection of SARS-CoV-2. Sensors, 20(20): 5871. https://doi.org/10.3390/s20205871
Velikova, Tsvetelina y Goergiev, Tsvetoslav. 2021. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Rheumatology International, 41: 509-518. https://doi.org/10.1007/s00296-021-04792-9
Ventura, Bartolomeo; Cennamo, Michele; Minopoli, Antonio; Campanile, Raffaele et al. 2020. Colorimetric test for fast detection of SARS-CoV-2 in nasal and throat swabs. ACS Sensors, 5(10): 3043-3048. https://doi.org/10.1021/acssensors.0c01742